Phase I study of autologous CD8+ and CD4+ transgenic T cells expressing high-affinity KRAS G12V mutation-specific T cell receptors (FH-A11KRASG12V-TCR) in patients with metastatic pancreatic, colorectal, and non-small cell lung cancers with KRAS G12V mutations.

AFNT-111 - Affini-T Therap

bendamustine - Generic mfg.

cyclophosphamide - Generic mfg.

fludarabine IV - Generic mfg.

https://meetings.asco.org/abstracts-presentations/241693/

Rachael Safyan; Mary Redman; Andrew Coveler; Stacey Cohen; Sylvia Lee; Cecilia Yeung; Thomas Schmitt; Aude Chapuis; Philip Greenberg; E. Gabriela Chiorean

Dec 17, 2024